Catalyst Wire Dossier Catalyst Wire Dossier

NANT NSCLC vaccine

NANT NSCLC vaccine · ImmunityBio, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NANT NSCLC vaccine, covering 2025-02-21 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors [Phase 1, Phase 2]

See pricing